In prostate carcinoma, both USP7 and MDM4 overexpression were associated with tumor aggressiveness, while both up- and down-regulation was found to inhibit colon carcinoma cell proliferation due to enhanced degradation of MDM2 following constitutively elevated p53 levels [21,35,36]. This evidence concerns the gene USP7 and prostate carcinoma.